Rebecca L. Harper

PPARγ-p53-Mediated Vasculoregenerative Program to Reverse Pulmonary Hypertension

Jan K. Hennigs, Aiqin Cao, Caiyun G. Li et al. · Circulation Research · 2020 · 86 citations · Full text

Medicine, Molecular Biology, Pharmacology +17

Role of endothelial cells in pulmonary fibrosis via SREBP2 activation

Marcy Martin, Jiao Zhang, Yifei Miao et al. · JCI Insight · 2021 · 47 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +16

Dysregulated Smooth Muscle Cell BMPR2–ARRB2 Axis Causes Pulmonary Hypertension

Lingli Wang, Jan-Renier Moonen, Aiqin Cao et al. · Circulation Research · 2023 · 47 citations · Full text

Life Sciences, Physiology, Medical Genetics +4

<scp>BMPR</scp>2 gene therapy for <scp>PAH</scp> acts via <scp>S</scp>mad and non‐<scp>S</scp>mad signalling

Rebecca L. Harper, Ann Reynolds, Claudine S. Bonder et al. · Respirology · 2016 · 44 citations

Medicine, Cardiology, Molecular Biology +17

iPSC–endothelial cell phenotypic drug screening and in silico analyses identify tyrphostin-AG1296 for pulmonary arterial hypertension

Mingxia Gu, Michele Donato, Minzhe Guo et al. · Science Translational Medicine · 2021 · 43 citations · Full text

Medicine, Bioinformatics, Pharmacology +11